Complete Filing Data
Tango Therapeutics, Inc. reported Stockholders Equity of $346.18 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Tango Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$101.6M | -$130.3M | -$101.7M | -$108.2M | -$58.2M | -$52.0M |
| Operating Income Loss | -$111.3M | -$145.6M | -$114.2M | -$111.1M | -$58.2M | -$52.2M |
| General And Administrative Expense | $41.5M | $43.7M | $35.5M | $30.0M | $17.6M | $9.9M |
| Other Comprehensive Income Loss Tax | -$112.0K | $150.0K | $3.9M | -$2.9M | -$782.0K | $7.0K |
| Income Tax Expense Benefit | $4.0K | $208.0K | $134.0K | $54.0K | $292.0K | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$101.6M | -$130.1M | -$101.6M | -$108.1M | -$57.9M | -$52.0M |
| Research And Development Expense | $132.2M | $143.9M | $115.2M | $105.9M | $77.6M | $50.0M |
| Other Nonoperating Income Expense | $4.1M | $7.6M | $5.9M | $1.5M | -$248.0K | $120.0K |
| Operating Expenses | $173.7M | $187.7M | $150.7M | $135.9M | $95.2M | $59.9M |
| Nonoperating Income Expense | $9.7M | $15.5M | $12.6M | $2.9M | $247.0K | $228.0K |
| Comprehensive Income Net Of Tax | -$101.7M | -$130.2M | -$97.9M | -$111.1M | -$59.0M | -$52.0M |
| Revenues | $62.4M | $42.1M | $36.5M | $24.9M | $37.0M | $7.7M |
| Interest Income Expense Net | $5.6M | $7.9M | $6.6M | $1.5M | $495.0K | $108.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $15.9M | -$38.9M | -$39.9M | -$29.2M | -$25.6M | -$37.9M | -$22.3M | -$20.7M | -$28.0M | -$29.1M | -$24.9M | -$25.2M | -$19.6M | -$4.5M | -$12.1M | -$26.8M | -$8.4M | -$7.9M |
| Operating Income Loss | $14.1M | -$41.0M | -$42.5M | -$32.9M | -$29.6M | -$42.3M | -$25.6M | -$23.2M | -$30.3M | -$29.9M | -$25.2M | -$25.4M | -$19.6M | -$4.6M | -$12.1M | -$26.8M | -$472.00 | |
| General And Administrative Expense | $8.9M | $11.3M | $11.5M | $11.2M | $10.8M | $10.7M | $9.2M | $9.2M | $8.0M | $8.1M | $7.2M | $6.8M | $4.4M | $3.6M | $3.5M | $2.5M | $472.00 | |
| Other Comprehensive Income Loss Tax | $27.0K | -$100.0K | -$142.0K | $1.1M | -$77.0K | -$443.0K | $836.0K | $684.0K | $1.5M | -$509.0K | -$937.0K | -$2.6M | -$12.0K | -$30.0K | $15.0K | $15.0K | -$14.0K | $15.0K |
| Income Tax Expense Benefit | -$10.0K | $35.0K | $34.0K | $54.0K | $65.0K | $40.0K | $23.0K | $64.0K | $0.00 | $0.00 | $3.0K | $0.00 | $62.0K | -$21.0K | $74.0K | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $15.9M | -$38.8M | -$39.8M | -$29.1M | -$25.5M | -$37.9M | -$22.2M | -$20.6M | -$28.0M | -$29.1M | -$24.9M | -$25.2M | -$19.5M | -$4.5M | -$12.0M | -$26.8M | -$472.00 | |
| Research And Development Expense | $30.8M | $32.8M | $36.4M | $33.3M | $38.7M | $38.1M | $27.1M | $28.7M | $28.0M | $28.7M | $23.7M | $24.3M | $21.9M | $19.1M | $15.0M | $13.0M | ||
| Other Nonoperating Income Expense | $705.0K | $910.0K | $1.1M | $2.0M | $2.0M | $2.2M | $1.5M | $1.2M | $1.2M | $523.0K | $50.0K | -$47.0K | -$50.0K | -$62.0K | -$55.0K | $4.0K | ||
| Operating Expenses | $39.7M | $44.1M | $47.9M | $44.5M | $49.4M | $48.7M | $36.4M | $37.8M | $36.1M | $36.8M | $31.0M | $31.1M | $26.4M | $22.7M | $18.5M | $15.5M | ||
| Nonoperating Income Expense | $1.8M | $2.1M | $2.7M | $3.8M | $4.1M | $4.4M | $3.4M | $2.6M | $2.3M | $873.0K | $347.0K | $171.0K | $41.0K | $42.0K | $49.0K | -$46.0K | ||
| Comprehensive Income Net Of Tax | $15.9M | -$39.0M | -$40.0M | -$28.1M | -$25.6M | -$38.4M | -$21.4M | -$20.0M | -$26.5M | -$29.6M | -$25.8M | -$27.9M | -$19.6M | -$4.5M | -$12.1M | -$26.8M | ||
| Revenues | $53.8M | $3.2M | $5.4M | $11.6M | $19.9M | $6.5M | $10.7M | $14.6M | $5.8M | $6.9M | $5.8M | $5.8M | $6.8M | $18.2M | $6.4M | -$11.3M | ||
| Interest Income Expense Net | $1.1M | $1.2M | $1.6M | $1.8M | $2.1M | $2.2M | $1.9M | $1.5M | $1.1M | $350.0K | $297.0K | $218.0K | $91.0K | $104.0K | $104.0K | -$50.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $346.2M | $199.5M | $253.1M | $249.5M | $344.7M | $38.6M | $7.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $114.8M | $72.1M | $69.8M | $64.0M | $145.0M | $30.7M | $25.2M |
| Marketable Securities Unrealized Gain Loss | -$112.0K | $150.0K | $3.9M | -$2.9M | -$782.0K | $7.0K | |
| Cash And Cash Equivalents At Carrying Value | $112.3M | $69.5M | $66.4M | $60.0M | $142.7M | $28.4M | |
| Retained Earnings Accumulated Deficit | -$603.2M | -$501.6M | -$371.3M | -$269.5M | -$161.3M | -$103.1M | |
| Liabilities Current | $21.7M | $38.2M | $45.9M | $55.5M | $40.7M | $40.9M | |
| Liabilities And Stockholders Equity | $398.7M | $316.5M | $402.6M | $436.5M | $500.2M | $207.3M | |
| Liabilities | $52.5M | $117.0M | $149.5M | $187.0M | $155.4M | $168.7M | |
| Common Stock Value | $136.0K | $108.0K | $102.0K | $88.0K | $88.0K | $40.0K | |
| Assets Current | $353.8M | $266.3M | $346.5M | $375.3M | $492.3M | $193.6M | |
| Assets | $398.7M | $316.5M | $402.6M | $436.5M | $500.2M | $207.3M | |
| Accounts Payable Current | $1.2M | $1.6M | $2.8M | $4.5M | $3.2M | $1.8M | |
| Operating Lease Right Of Use Asset Amortization Expense | $4.0M | $3.7M | $3.6M | $2.4M | $1.1M | $907.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $42.7M | $2.3M | $5.9M | -$81.1M | $114.4M | $5.5M | |
| Operating Lease Right Of Use Asset | $35.6M | $39.5M | $43.5M | $46.9M | $1.3M | $7.5M | |
| Cash Paid For Leases | $5.9M | $5.6M | $5.9M | $1.4M | -$1.8M | -$1.8M | |
| Restricted Cash Noncurrent | $2.1M | $2.6M | $2.6M | $3.4M | $1.7M | $2.3M | |
| Property Plant And Equipment Net | $6.9M | $8.1M | $9.9M | $10.9M | $4.8M | $3.8M | |
| Prepaid Expense And Other Assets Current | $10.2M | $8.4M | $8.8M | $6.6M | $4.5M | $1.3M | |
| Other Assets Noncurrent | $303.0K | $4.0K | $46.0K | $5.0K | $19.0K | $38.0K | |
| Operating Lease Liability Current | $2.7M | $2.5M | $2.1M | $1.8M | $1.5M | $959.0K | |
| Marketable Securities Current | $230.9M | $188.4M | $270.5M | $306.2M | $342.5M | $161.9M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $224.0K | $336.0K | $186.0K | -$3.7M | -$765.0K | $17.0K | |
| Accrued Expenses And Other Current Liabilities | $17.8M | $16.5M | $15.4M | $17.5M | $9.9M | $6.1M | |
| Contract With Customer Liability Noncurrent | $0.00 | $44.8M | $66.7M | $92.1M | $114.7M | $120.8M | |
| Contract With Customer Liability Current | $0.00 | $17.6M | $25.7M | $31.8M | $26.0M | $32.0M | |
| Operating Lease Liability Noncurrent | $30.8M | $34.0M | $36.8M | $39.4M | $6.9M | ||
| Restricted Cash Current | $428.0K | $900.0K | $856.0K | $567.0K | $567.0K | ||
| Revaluation Of Right Of Use Asset And Lease Liability Upon Lease Modification | $1.2M | $497.0K | -$228.0K | $300.0K | $5.3M | ||
| Accounts Receivable Net Current | $2.0M | $2.0M | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $160.0M | $135.0M | $166.8M | $229.2M | $247.7M | $264.5M | $276.6M | $212.9M | $227.3M | $273.1M | $298.7M | $320.4M | $365.4M | $54.9M | $57.9M | $46.9M | $22.2M | $417.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $60.9M | $41.8M | $61.0M | $55.7M | $54.1M | $63.7M | $62.0M | $69.5M | $60.7M | $104.3M | $108.6M | $103.9M | $207.3M | $53.2M | $68.1M | $108.0M | ||
| Marketable Securities Unrealized Gain Loss | $27.0K | -$100.0K | -$142.0K | $1.1M | -$77.0K | -$443.0K | $836.0K | $684.0K | $1.5M | -$509.0K | -$937.0K | -$2.6M | -$12.0K | -$30.0K | $15.0K | $15.0K | ||
| Cash And Cash Equivalents At Carrying Value | $58.3M | $39.3M | $58.4M | $53.1M | $51.6M | $61.2M | $58.5M | $66.1M | $57.3M | $100.3M | $104.6M | $99.9M | $205.0M | $582.9K | $1.3M | $1.6M | $25.0K | |
| Retained Earnings Accumulated Deficit | -$564.4M | -$580.3M | -$541.4M | -$463.9M | -$434.7M | -$409.2M | -$340.5M | -$318.2M | -$297.5M | -$240.5M | -$211.4M | -$186.5M | -$139.3M | -$1.1M | -$362.8K | -$52.9K | ||
| Liabilities Current | $18.4M | $40.0M | $35.9M | $37.6M | $43.9M | $42.8M | $43.4M | $53.6M | $53.7M | $51.3M | $44.7M | $39.2M | $42.0M | $355.2K | $302.0K | $115.1K | ||
| Liabilities And Stockholders Equity | $210.1M | $237.9M | $274.3M | $352.4M | $381.5M | $406.2M | $428.2M | $379.3M | $403.8M | $464.2M | $448.4M | $471.5M | $530.1M | $167.5M | $168.3M | $168.4M | ||
| Liabilities | $50.1M | $102.9M | $107.6M | $123.2M | $133.8M | $141.8M | $151.6M | $166.4M | $176.5M | $191.1M | $149.7M | $151.2M | $164.7M | $6.2M | $6.1M | $6.0M | ||
| Common Stock Value | $112.0K | $111.0K | $108.0K | $107.0K | $107.0K | $107.0K | $102.0K | $88.0K | $88.0K | $88.0K | $88.0K | $88.0K | $88.0K | $574.00 | $566.00 | $563.00 | ||
| Assets Current | $163.8M | $190.1M | $224.9M | $300.8M | $328.4M | $352.0M | $370.9M | $320.5M | $343.0M | $401.7M | $436.1M | $460.7M | $516.3M | $734.3K | $1.5M | $1.6M | ||
| Assets | $210.1M | $237.9M | $274.3M | $352.4M | $381.5M | $406.2M | $428.2M | $379.3M | $403.8M | $464.2M | $448.4M | $471.5M | $530.1M | $167.5M | $168.3M | $168.4M | ||
| Accounts Payable Current | $2.2M | $2.6M | $3.2M | $4.1M | $1.1M | $3.9M | $2.8M | $4.8M | $6.3M | $6.3M | $1.7M | $3.4M | $3.1M | $26.3K | $68.3K | $5.2K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $1.0M | $925.0K | $877.0K | $361.0K | $242.0K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$11.1M | -$6.1M | -$3.3M | -$41.1M | $37.4M | |||||||||||||
| Operating Lease Right Of Use Asset | $36.6M | $37.6M | $39.7M | $40.4M | $41.4M | $42.1M | $44.4M | $45.3M | $46.2M | $47.8M | $520.0K | $894.0K | $6.7M | |||||
| Cash Paid For Leases | $1.9M | $1.4M | $746.0K | $465.0K | $452.0K | |||||||||||||
| Restricted Cash Noncurrent | $2.1M | $2.1M | $2.1M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $3.4M | $3.4M | $3.4M | $3.4M | $2.3M | |||||
| Property Plant And Equipment Net | $7.3M | $7.8M | $7.5M | $8.6M | $9.1M | $9.5M | $10.3M | $10.9M | $11.1M | $11.3M | $8.4M | $6.5M | $4.7M | |||||
| Prepaid Expense And Other Assets Current | $10.5M | $8.9M | $7.8M | $7.5M | $6.3M | $8.4M | $10.2M | $9.0M | $9.4M | $5.8M | $17.2M | $8.2M | $4.5M | |||||
| Other Assets Noncurrent | $290.0K | $310.0K | $1.0K | $13.0K | $10.0K | $11.0K | $48.0K | $12.0K | $19.0K | $6.0K | $12.0K | $16.0K | $81.0K | |||||
| Operating Lease Liability Current | $3.1M | $2.5M | $2.8M | $2.9M | $2.4M | $2.1M | $2.0M | $1.8M | $2.6M | $781.0K | $629.0K | $1.1M | $1.1M | |||||
| Marketable Securities Current | $94.5M | $141.5M | $158.3M | $240.1M | $270.5M | $282.4M | $301.3M | $244.6M | $276.4M | $293.0M | $311.8M | $350.0M | $298.8M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $121.0K | $94.0K | $194.0K | $750.0K | -$334.0K | -$257.0K | -$681.0K | -$1.5M | -$2.2M | -$4.9M | -$4.3M | -$3.4M | -$10.0K | |||||
| Accrued Expenses And Other Current Liabilities | $13.1M | $11.5M | $10.4M | $15.0M | $16.8M | $13.8M | $11.5M | $13.2M | $10.7M | $15.8M | $14.2M | $9.7M | $10.0M | |||||
| Contract With Customer Liability Noncurrent | $0.00 | $30.4M | $37.5M | $50.9M | $54.4M | $62.8M | $70.7M | $74.7M | $84.1M | $99.8M | $105.0M | $112.0M | $116.6M | |||||
| Contract With Customer Liability Current | $0.00 | $23.4M | $19.5M | $15.6M | $23.7M | $23.1M | $27.1M | $33.8M | $34.0M | $28.5M | $28.2M | $25.0M | $27.8M | |||||
| Operating Lease Liability Noncurrent | $31.7M | $32.5M | $34.1M | $34.8M | $35.5M | $36.2M | $37.5M | $38.1M | $38.7M | $39.9M | $6.1M | |||||||
| Restricted Cash Current | $428.0K | $428.0K | $428.0K | $856.0K | $856.0K | $567.0K | $567.0K | $567.0K | ||||||||||
| Revaluation Of Right Of Use Asset And Lease Liability Upon Lease Modification | $75.0K | $497.0K | -$215.0K | |||||||||||||||
| Accounts Receivable Net Current | $2.0M | $2.0M | $2.0M | $8.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $26.4M | $28.9M | $19.1M | $14.2M | $7.8M | $1.8M |
| Net Cash Provided By Used In Operating Activities | -$138.9M | -$131.5M | -$118.0M | -$109.1M | -$59.5M | $70.1M |
| Net Cash Provided By Used In Investing Activities | -$40.9M | $86.1M | $41.4M | $26.4M | -$183.4M | -$145.5M |
| Net Cash Provided By Used In Financing Activities | $222.5M | $47.7M | $82.4M | $1.6M | $357.3M | $80.9M |
| Share Based Compensation | $26.4M | $28.9M | $19.1M | $14.2M | $7.8M | $1.8M |
| Proceeds From Sale And Maturity Of Marketable Securities | $224.6M | $327.8M | $353.5M | $242.6M | $190.8M | $63.2M |
| Payments To Acquire Property Plant And Equipment | $1.0M | $754.0K | $1.5M | $7.7M | $1.8M | $1.1M |
| Payments To Acquire Marketable Securities | $264.5M | $240.9M | $310.6M | $208.5M | $372.4M | $207.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.8M | -$370.0K | $2.2M | $2.1M | $3.2M | $81.0K |
| Increase Decrease In Operating Lease Liabilities | -$3.0M | -$2.1M | -$2.4M | $1.7M | -$1.1M | -$655.0K |
| Increase Decrease In Deferred Revenue | -$62.4M | -$30.0M | -$31.5M | -$16.9M | -$12.0M | $119.1M |
| Increase Decrease In Accrued Expenses And Other Liabilities | $1.1M | $1.1M | -$2.0M | $7.6M | $3.8M | $1.2M |
| Increase Decrease In Accounts Payable Trade | -$825.0K | -$1.2M | -$1.7M | $1.1M | $1.2M | $1.2M |
| Increase Decrease In Other Noncurrent Assets | $299.0K | -$43.0K | $41.0K | -$122.0K | $139.0K | $38.0K |
| Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options And Purchase Of Shares Under Employee Stock Purchase Plans | 10.1M | 5.9M | 1.9M | 1.6M | 1.1M | |
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition | $6.0K | $12.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $6.6M | $6.6M | $7.3M | $7.2M | $7.5M | $6.7M | $4.9M | $5.1M | $4.2M | $3.8M | $3.4M | $3.2M | $3.4M | $1.2M | $950.0K | $418.0K | $407.0K | $408.0K |
| Net Cash Provided By Used In Operating Activities | -$41.7M | -$37.9M | -$34.9M | -$29.7M | -$13.6M | -$89.3K | -$32.00 | |||||||||||
| Net Cash Provided By Used In Investing Activities | $30.6M | -$11.2M | $31.6M | -$11.7M | $20.6M | -$166.8M | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $2.0K | $43.0M | $73.0K | $257.0K | $30.4M | $168.4M | $25.0K | |||||||||||
| Share Based Compensation | $7.3M | $6.7M | $4.2M | $3.2M | $950.0K | |||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $77.8M | $109.3M | $84.7M | $44.4M | $40.6M | |||||||||||||
| Payments To Acquire Property Plant And Equipment | $51.0K | $195.0K | $620.0K | $1.6M | $165.0K | |||||||||||||
| Payments To Acquire Marketable Securities | $47.2M | $120.3M | $52.5M | $54.6M | $19.9M | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$649.0K | -$360.0K | $2.8M | $3.7M | $132.0K | |||||||||||||
| Increase Decrease In Operating Lease Liabilities | -$780.0K | -$188.0K | $26.0K | -$429.0K | -$372.0K | |||||||||||||
| Increase Decrease In Deferred Revenue | -$5.4M | -$6.5M | -$5.8M | -$3.8M | -$4.4M | |||||||||||||
| Increase Decrease In Accrued Expenses And Other Liabilities | -$6.1M | -$1.6M | -$6.7M | -$157.0K | -$636.0K | |||||||||||||
| Increase Decrease In Accounts Payable Trade | $1.6M | $1.0M | $1.6M | -$359.0K | $2.6M | |||||||||||||
| Increase Decrease In Other Noncurrent Assets | -$1.0K | -$35.0K | $13.0K | -$4.0K | -$8.0K | |||||||||||||
| Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options And Purchase Of Shares Under Employee Stock Purchase Plans | 2.0K | 1.3M | 73.0K | |||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition | $3.0K | $2.0K | $3.0K | $3.0K | $3.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.87 | -$1.19 | -$1.08 | -$1.23 | -$0.94 | -$1.63 |
| Common Stock Shares Outstanding | 135.9M | 107.7M | 102.2M | 88.2M | 87.6M | 40.4M |
| Common Stock Shares Authorized | 400.0M | 200.0M | 200.0M | 200.0M | 200.0M | 56.4M |
| Common Stock Shares Issued | 135.9M | 107.7M | 102.2M | 88.2M | 87.6M | 40.4M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 116.2M | 109.2M | 94.6M | 87.8M | 62.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 116.2M | 109.2M | 94.6M | 87.8M | 62.1M | |
| Earnings Per Share Basic | $-0.87 | $-1.19 | $-1.08 | $-1.23 | $-0.94 | |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Temporary Equity Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Temporary Equity Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 62.1M | 31.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.13 | -$0.35 | -$0.36 | -$0.27 | -$0.24 | -$0.35 | -$0.23 | -$0.23 | -$0.32 | -$0.33 | -$0.28 | -$0.29 | -$0.28 | -$0.09 | -$0.29 | -$0.76 | |
| Common Stock Shares Outstanding | 111.6M | 110.9M | 108.1M | 107.4M | 107.0M | 106.7M | 101.8M | 88.5M | 88.2M | 88.1M | 88.0M | 87.7M | 87.5M | 5.7M | 5.7M | 5.6M | |
| Common Stock Shares Authorized | 400.0M | 400.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 30.0M | 30.0M | 30.0M | |
| Common Stock Shares Issued | 111.6M | 110.9M | 108.1M | 107.4M | 107.0M | 106.7M | 101.8M | 88.5M | 88.2M | 88.1M | 88.0M | 87.7M | 87.5M | 5.7M | 5.7M | 5.6M | 55.7M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 111.0M | 110.5M | 110.3M | 108.5M | 108.3M | 108.2M | 97.0M | 88.4M | 88.2M | 87.9M | 87.8M | 87.7M | 70.2M | 48.5M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 117.8M | 110.5M | 110.3M | 108.5M | 108.3M | 108.2M | 97.0M | 88.4M | 88.2M | 87.9M | 87.8M | 87.7M | 70.2M | 48.5M | |||
| Earnings Per Share Basic | $0.14 | $-0.35 | $-0.36 | $-0.27 | $-0.24 | $-0.35 | $-0.23 | $-0.23 | $-0.32 | $-0.33 | $-0.28 | $-0.29 | $-0.28 | $-0.09 | |||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Temporary Equity Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Temporary Equity Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 87.7M | 70.2M | 16.7M | 41.6M | 35.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation | $2.3M | $2.5M | $2.4M | $1.6M | $897.0K | $718.0K |
| Other Noncash Income Expense | $77.0K | -$23.0K | -$22.0K | $669.0K | -$254.0K | $17.0K |
| Additional Paid In Capital | $949.0M | $700.6M | $624.1M | $522.6M | $506.8M | $141.6M |
| Capital Expenditures Incurred But Not Yet Paid | $38.0K | $131.0K | $154.0K | $29.0K | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $10.1M | $5.9M | $1.9M | |||
| Stock Issued During Period Value Stock Options Exercised | $1.1M | $40.0K | ||||
| Stock Issued During Period Value Stock Options And Employee Stock Purchase Plan Exercised | $5.9M | $1.9M | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $622.0K | $625.0K | $581.0K | $309.0K | $200.0K | $204.0K | $200.0K | ||||||||||
| Other Noncash Income Expense | $56.0K | $10.0K | -$4.0K | -$54.0K | -$58.0K | ||||||||||||
| Additional Paid In Capital | $724.2M | $715.0M | $707.9M | $692.2M | $682.6M | $673.8M | $617.7M | $532.6M | $526.9M | $518.3M | $514.4M | $510.2M | $504.6M | ||||
| Capital Expenditures Incurred But Not Yet Paid | $8.0K | $71.0K | $290.0K | $500.0K | $81.0K | ||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $2.5M | $581.0K | $2.0K | $2.4M | $1.3M | $1.3M | $441.0K | $586.0K | $73.0K | ||||||||
| Stock Issued During Period Value Stock Options Exercised | $265.0K | $193.0K | $324.0K | $440.0K | $1.0K | $9.0K | |||||||||||
| Stock Issued During Period Value Stock Options And Employee Stock Purchase Plan Exercised | $441.0K | $586.0K | $73.0K | $112.0K | $718.0K | $265.0K |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.